Concepedia

Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

Esther Chamorro‐de‐Vega, Álvaro Giménez‐Manzorro, Carmen Guadalupe Rodríguez-González, Vicente Escudero‐Vilaplana, Roberto Collado Borrell, Sara Ibáñez-García, Elena Lallana Sainz, Elena Lobato Matilla, Ana de Lorenzo‐Pinto, Silvia Manrique‐Rodríguez,

Annals of Pharmacotherapy · 2016 · 11 citations · 20 references

DOI

Abstract

The combination of OBV/PTV/r+DSV with or without ribavirin for 12-week settings achieved a high rate of SVR12, with an acceptable safety profile in routine clinical care.

References

20

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano, Mohsen Naghavi, Kyle J Foreman et al. · The Lancet · 2012 · 14.1K citations · Full text

An Algorithm for the Grading of Activity in Chronic Hepatitis C

Pierre Bédossa, Thierry Poynard · Hepatology · 1996 · 4K citations · Full text

, , +14

Surgery and portal hypertension.

Charles G. Child, J Turcotte · PubMed · 1964 · 1.8K citations

, , +4

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

John G. McHutchison, Eric Lawitz, Mitchell L. Shiffman et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text

EASL Recommendations on Treatment of Hepatitis C 2015

Journal of Hepatology · 2015 · 1.2K citations

, , +4